Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.
Clinical trial NCT00714285 · COMPLETED
Trial details
- NCT number
- NCT00714285
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-14
- Primary completion
- 2009-01-28
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.